DOKRINAS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 36,098 | 48,775 | 183,886 | 119,647 | 107,120 | 109,812 | 129,124 | 177,926 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -181 | 1,601 | 52,699 | 12,189 | 11,081 | 17,493 | -6,929 | 14,132 |
| Equity | 22,817 | 24,839 | 86,721 | 98,949 | 99,835 | 118,775 | 14,587 | 30,159 |
| Liabilities | 4,721 | 6,576 | 8,378 | 2,257 | 12,275 | 13,772 | 23,854 | 16,755 |
| Non-current assets | 1,896 | 1,445 | 21,274 | 19,312 | 17,149 | 16,120 | 13,715 | 11,294 |
| Current assets | 25,642 | 30,049 | 73,865 | 81,950 | 95,445 | 116,707 | 24,726 | 35,620 |
| Total assets | 27,538 | 31,494 | 95,139 | 101,262 | 112,594 | 132,827 | 38,441 | 46,914 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 12,025 | 32,114 | 23,603 |
| Social insurance contributions | - | - | - | - | - | 13,045 | 17,829 | 22,102 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -15.3% | +35.1% | +277.0% | -34.9% | -10.5% | +2.5% | +17.6% | +37.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -0.7% | 5.1% | 55.4% | 12.0% | 9.8% | 13.2% | -18.0% | 30.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -0.8% | 6.4% | 60.8% | 12.3% | 11.1% | 14.7% | -47.5% | 46.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -0.5% | 3.3% | 28.7% | 10.2% | 10.3% | 15.9% | -5.4% | 7.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.3 | 0.1 | 0.0 | 0.1 | 0.1 | 1.6 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 4,560 | 5,574 | 18,700 | 12,168 | 11,902 | 13,311 | 15,974 | 18,249 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
DOKRINAS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-29 | 2026-08-02 | 4.77 |
| 2026-07-23 | 2026-07-26 | 4.77 |
| 2026-05-17 | 2026-05-31 | 0.01 |
| 2026-04-20 | 2026-04-22 | 2296.13 |
| 2022-11-17 | 2022-11-18 | 117.84 |
DOKRINAS - VMI tax arrears
As of 2026-09-20, the amount of overdue STI tax debt of the company DOKRINAS is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-08 | 2026-09-20 | 0.06 |
| 2026-07-05 | 2026-08-06 | 0.06 |
| 2025-03-02 | 2025-03-12 | 3.31 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
DOKRINAS, UAB (code 124206091) is a Private Limited Liability Company operating in legal activities. In 2025, the company generated revenue of €177.9K and net profit of €14.1K, giving a profit margin of 7.9%. Revenue increased by 37.8% year on year and by 62.0% over two years, showing a clear upward top-line trend. Profitability was more volatile: the company earned €17.5K in 2023, reported a loss of €6.9K in 2024, and returned to profit in 2025. The latest balance sheet shows total assets of €46.9K, equity of €30.2K and liabilities of €16.8K. Equity ratio stood at 64.3%, while debt-to-equity was 0.56. Return on equity reached 46.9% and return on assets 30.1%, supported by an asset turnover of 3.79x. Revenue per employee was €19.8K and profit per employee €1.6K. Overall, 2025 reflects stronger growth and a recovery in profitability after the weaker 2024 result.